These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23933005)

  • 1. A dynamic population model for estimating all-cause mortality due to lifetime exposure history.
    Bachand AM; Sulsky SI
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):246-51. PubMed ID: 23933005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Markov series and Monte Carlo simulation in predicting replacement valve performances.
    de Kruyk AR; van der Meulen JH; van Herwerden LA; Bekkers JA; Steyerberg EW; Dekker R; Habbema JD
    J Heart Valve Dis; 1998 Jan; 7(1):4-12. PubMed ID: 9502132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management and burden of prostate cancer: a Markov Monte Carlo model.
    Sanyal C; Aprikian A; Cury F; Chevalier S; Dragomir A
    PLoS One; 2014; 9(12):e113432. PubMed ID: 25474006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age.
    Allen BC; Hack CE; Clewell HJ
    Risk Anal; 2007 Aug; 27(4):947-59. PubMed ID: 17958503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the health impacts of tobacco harm reduction policies: a simulation modeling approach.
    Ahmad S; Billimek J
    Risk Anal; 2005 Aug; 25(4):801-12. PubMed ID: 16268930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Likelihood and Magnitude of a Population Health Benefit Following the Market Introduction of a Modified-Risk Tobacco Product: Enhancements to the Dynamic Population Modeler, DPM(+1).
    Bachand AM; Sulsky SI; Curtin GM
    Risk Anal; 2018 Jan; 38(1):151-162. PubMed ID: 28437870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Decision Model Suggests Total Shoulder Arthroplasty is Superior to Hemiarthroplasty in Young Patients with End-stage Shoulder Arthritis.
    Bhat SB; Lazarus M; Getz C; Williams GR; Namdari S
    Clin Orthop Relat Res; 2016 Nov; 474(11):2482-2492. PubMed ID: 27457626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era.
    King JT; Justice AC; Roberts MS; Chang CC; Fusco JS;
    Med Decis Making; 2003; 23(1):9-20. PubMed ID: 12583451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining transition probabilities from mortality rates and autopsy findings.
    Black WC; Nease RF; Welch HG
    Med Decis Making; 1997; 17(1):87-93. PubMed ID: 8994155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parameter and model uncertainty in a life-table model for fine particles (PM2.5): a statistical modeling study.
    Tainio M; Tuomisto JT; Hänninen O; Ruuskanen J; Jantunen MJ; Pekkanen J
    Environ Health; 2007 Aug; 6():24. PubMed ID: 17714598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the theoretical foundations of the exponential and beta-Poisson dose-response models to quantify parameter uncertainty using Markov Chain Monte Carlo.
    Schmidt PJ; Pintar KD; Fazil AM; Topp E
    Risk Anal; 2013 Sep; 33(9):1677-93. PubMed ID: 23311599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting.
    Zhang Y; Kivipelto M; Solomon A; Wimo A
    J Alzheimers Dis; 2011; 26(4):735-44. PubMed ID: 21709377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.
    Dewji S; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
    Med Phys; 2015 Apr; 42(4):1851-7. PubMed ID: 25832075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent mixed Markov modelling of smoking transitions using Monte Carlo bootstrapping.
    Mannan HR; Koval JJ
    Stat Methods Med Res; 2003 Mar; 12(2):125-46. PubMed ID: 12665207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refined avian risk assessment for chlorpyrifos in the United States.
    Moore DR; Teed RS; Greer CD; Solomon KR; Giesy JP
    Rev Environ Contam Toxicol; 2014; 231():163-217. PubMed ID: 24723136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of heterogeneity in malaria transmission by stochastic modelling of apparent deviations from mass action kinetics.
    Smith TA
    Malar J; 2008 Jan; 7():12. PubMed ID: 18190717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter regarding: Allen, B. M., Hack, C. E., & Clewell, H. J. (2007). Use of Markov Chain Monte Carlo analysis with a physiologically based pharmacokinetic model of methylmercury to estimate exposure in U.S. women of childbearing age. Risk Analysis, 27(1), 947-959.
    Carrington CD; Bolger M
    Risk Anal; 2008 Oct; 28(5):1137-40. PubMed ID: 18844860
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.